Compare GSL & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSL | NEOG |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2006 | 1989 |
| Metric | GSL | NEOG |
|---|---|---|
| Price | $34.87 | $7.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $39.00 | $8.83 |
| AVG Volume (30 Days) | 358.1K | ★ 3.4M |
| Earning Date | 11-10-2025 | 01-08-2026 |
| Dividend Yield | ★ 7.16% | N/A |
| EPS Growth | ★ 24.38 | N/A |
| EPS | ★ 11.14 | N/A |
| Revenue | $747,044,000.00 | ★ $886,886,000.00 |
| Revenue This Year | $6.69 | N/A |
| Revenue Next Year | N/A | $1.80 |
| P/E Ratio | $3.13 | ★ N/A |
| Revenue Growth | ★ 6.50 | N/A |
| 52 Week Low | $17.73 | $3.87 |
| 52 Week High | $37.22 | $13.41 |
| Indicator | GSL | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 53.86 | 63.95 |
| Support Level | $34.15 | $6.89 |
| Resistance Level | $35.49 | $7.29 |
| Average True Range (ATR) | 0.68 | 0.25 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 74.18 | 69.06 |
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.